Our Paraquat Litigation Team members will be happy to answer any questions about the status of this litigation or the intricacies of the intake process, including the Plaintiffs Assessment Questionnaire
Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder caused by defects in hepatic glycoxidation metabolism, leading to excessive endogenous oxalate production
488,489 Several NADs have been approved for ATTR treatment, including ASOs, such as inotersen 490,491 and eplontersen, 492 as well as siRNAs, such as patisiran 97 and vutrisiran
Most patients need 2-3 sessions spaced 3-4 weeks apart for optimal results
For others, who may be worried about the potential negative side effects, Kumar recommends scheduling a consultation or longer appointment with your doctor and having them walk you through the most common side effects, how severe they can be and then discussing the less common side effects that you may not be aware of
Peptides like GHK-Cu directly stimulate dermal papilla cells